Bristol-Myers Squibb Could Finally Go on the Market; Rumored Suitors Include Gilead, Pfizer, Novartis AG and Roche Post author:Sam Post published:February 13, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Sanofi Investors Crave for a Large Acquisition, Drug News December 11, 2017 Invacare Proposes $100 Million Raise June 8, 2017 Genentech's $94,000-a-Year Drug Tarceva: Why Faster FDA Approvals Could Backfire February 6, 2017